Australia's best minds in melanoma research converge on Melbourne
8 October 2018
The 2018 Australasian Melanoma Conference, held in Melbourne over the weekend, focussed on the integration of research and clinical care.
Melanoma Institute Australia’s Medical Directors, Professor Georgina Long and Professor Richard Scolyer, led the large contingent from MIA. In the targeted therapies session, Professor Long asked “where to next?”, while Professor Scolyer spoke on the challenges associated with borderline lesions and, in the Saturday lunchtime plenary session, discussed predicting patient outcomes.
Among the team of MIA clinicians was Professor Graham Mann who presented insights from the Australian Melanoma Genome Project and the Australian Melanoma Clinical Outcomes Registry. Associate Professor Pascale Guitera spoke on dermoscopy and provided an educational course on confocal microscopy, and Associate Professor Jon Stretch, Professor Angela Hong, Professor Peter Hersey and research affiliates Professor Nick Hayward and Professor Helen Rizos all chaired sessions.
A joint presentation from Professor Andrew Spillane and Associate Professor Alex Menzies in the management of loco-regional disease session provided both surgical and medical approaches to regional disease. Professor Diona Damian debated topical and injectable therapies for cutaneous melanoma, and Associate Professor Robyn Saw discussed follow-up and investigation for high-risk melanoma patients in the supportive care and survivorship session. A clinician’s perspective of The National Melanoma Guidelines from Professor John Thompson rounded out the weekend.
A highlight of the conference was the Consumer Breakfast, where a panel of people affected by melanoma, including MIA’s Jay Allen, discussed solariums, early detection, and the importance of support and routines after diagnosis. They shared stories, hope, and the importance of fundraising. “We need to keep raising funds, by organising events in local areas or supporting larger fundraising campaigns, because without funding, we don’t have research,” Mr Allen said.
Photograph: Australasian Melanoma Conference
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.